Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-3921

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-3921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepinstructure (Oxcarbazepinstructure)

Oxcarbazepinstructure (Oxcarbazepinstructure)
Chemical structure diagram of Oxcarbazepine, showing its core ring system and functional groups as part of the molecular formula representation.*
FDA Label Image

Oxcarbazepinfig1 (Oxcarbazepinfig1)

Oxcarbazepinfig1 (Oxcarbazepinfig1)
A Kaplan-Meier survival curve chart comparing the exit rate over time from Day 2 to Day 11 between two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The x-axis represents time in days, and the y-axis represents the exit rate. A log-rank test indicates a p-value of 0.0001.*
FDA Label Image

Oxcarbazepinfig2 (Oxcarbazepinfig2)

Oxcarbazepinfig2 (Oxcarbazepinfig2)
A Kaplan-Meier graph depicting seizure rates over time from the first dose to the first seizure. The x-axis represents days up to 140, and the y-axis represents seizure rate from 0.0 to 1.0. Two treatment groups are compared: Oxcarbazepine (solid line) and Placebo (dashed line). The graph also displays a log-rank test p-value of 0.046.*
FDA Label Image

Oxcarbazepinfig3 (Oxcarbazepinfig3)

Oxcarbazepinfig3 (Oxcarbazepinfig3)
A Kaplan-Meier plot showing exit rate over time (days) for two treatment groups labeled High and Low. The vertical axis represents exit rate from 0 to 1, and the horizontal axis represents time to exit in days up to approximately 140 days. The chart compares exit rates between the two treatment groups over the study period.*
FDA Label Image

Oxcarbazepinfig4 (Oxcarbazepinfig4)

Oxcarbazepinfig4 (Oxcarbazepinfig4)
A Kaplan-Meier survival curve illustrating exit rates over time in days for two treatment groups labeled 'High' and 'Low'. The vertical axis represents the exit rate from 0.0 to 1.0, and the horizontal axis shows time to exit from 0 to 140 days. The 'Low' group curve rises more steeply and reaches a higher exit rate earlier than the 'High' group. A log-rank test p-value of 0.0001 is displayed, indicating statistical difference between groups.*
FDA Label Image

Mm1 (Oxcarbazepine 300mg 70518 3921 00)

Mm1 (Oxcarbazepine 300mg 70518 3921 00)
Oxcarbazepine 300 mg film-coated tablets, packaged 100 per box. The label shows the active ingredient name, strength, package quantity, and labeler as RemedyRepack Inc. It includes instructions to see the insert for dosage and storage conditions, with a QR code present. The manufacturer is Camber Pharma, Inc., Piscataway, NJ.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Oxcarbazepine 300 mg film-coated tablets, packaged 100 per box. The label is from RemedyRepack Inc. and includes a barcode, NDC 70518-3921-00, storage instructions at 20-25°C with permitted excursions, and advises to see the package insert for directions. Manufacturer: Camber Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.